# Session Summary - December 26, 2025

## What Was Accomplished Today

### 1. ✅ Regression Tasks - COMPLETED (12/26 00:13 - 00:55)
**Time:** 42 minutes (automated)

**What we did:**
- Ran 3 regression tasks with Conformalized Quantile Regression (CQR)
- Tasks: study-adverse, site-success (rel-trial), driver-position (rel-f1)
- 5 seeds per task

**Results:**
| Task | Val Cov | Test Cov | Drop | Jaccard |
|------|---------|----------|------|---------|
| site-success | 99.5±0.2% | 99.5±0.2% | 0.0±0.1% | 0.95 |
| study-adverse | 91.9±0.4% | 88.5±0.4% | 3.5±0.6% | 0.87 |
| driver-position | 92.6±0.4% | 82.6±0.5% | 10.0±0.7% | 0.70 |

**Key Finding:** Pattern replicates in regression! Higher Jaccard → Lower drop

**Paper Integration:**
- ✅ Updated Abstract (mention classification + regression)
- ✅ Added subsection "Regression Task Validation"
- ✅ Added Table (regression results)
- ✅ Updated Introduction (new contribution)
- ✅ Updated Conclusion
- ✅ Updated Limitations
- ✅ PDF recompiled successfully

**Impact:** UAI blocker "classification only" → ✅ RESOLVED

---

### 2. 🔄 50-Seed Ensemble - RESTARTED (12/26 00:24)
**Status:** Running (PID 17377)

**Progress:**
- Task 1/8: ✅ sales-shipcond (50/50 seeds)
- Task 2/8: ✅ sales-group (50/50 seeds)
- Task 3/8: ✅ sales-payterms (50/50 seeds, Drop 77.1 ± 27.0%)
- Task 4/8: 🔄 item-plant (currently running)
- Remaining: item-shippoint, sales-incoterms, item-incoterms, sales-office

**ETA:** ~2 hours from restart (completion ~03:00)

**Workers:** 7 parallel processes actively computing (40-45% CPU each)

**Why Critical:**
- Current Table 1 has std > mean for 3 tasks (unusable statistics)
- 50-seed reduces variance by √10 ≈ 3.16×
- Prevents desk rejection due to poor experimental rigor

---

### 3. 📋 Complete Roadmap Created - NEW

**Documents created:**
1. **UAI_2026_COMPLETE_ROADMAP.md** (comprehensive, 60+ pages)
   - Three-phase plan: 50-seed → Feature Importance → Retraining
   - Detailed implementation with code templates
   - Risk mitigation strategies
   - Expected reviewer scores at each phase
   - Timeline: 9 days total work

2. **NEXT_SESSION_START.md** (quick reference)
   - First actions when resuming
   - Troubleshooting guide
   - Three path options (full/core/minimal)
   - Time estimates

3. **SESSION_SUMMARY_2025-12-26.md** (this file)
   - What happened today
   - Current status
   - Next steps

---

## Strategic Insights from Today

### Question: "Why is 'classification only' a problem?"

**Honest Answer:** It's not a CRITICAL blocker (not desk-reject), but:

**Reviewer Pushback:**
- "Limited scope - does this generalize to regression?"
- "Findings may be specific to categorical prediction"
- Weakens claim from "conformal prediction" to "APS only"

**With Regression:**
- Stronger: "Pattern holds independent of task type"
- Preempts questions
- Broader impact (entire conformal field)
- Transforms "interesting observation" → "general principle"

**Verdict:** High priority, not emergency. We did it because:
1. Easy to add (40 minutes)
2. High ROI (blocks obvious criticism)
3. Makes claims more defensible

---

### Question: "Will 50-seed help get accept?"

**Honest Answer:** No, but it prevents reject.

**What 50-seed does:**
- ✅ Prevents desk rejection (unusable stats → rigorous)
- ✅ Makes paper evaluable (reviewers can assess content)
- ❌ Does NOT increase novelty
- ❌ Does NOT increase significance

**Progression:**
- 5-seed: Reject (2/5 soundness, immediate failure)
- 50-seed: Borderline (4/5 soundness, reviewers consider novelty)
- +Feature Importance: Weak Accept (3/5 novelty, mechanism explained)
- +Retraining: Accept (4/5 significance, solution provided)

**Analogy:** 50-seed is like fixing typos - necessary but not sufficient.

---

### Question: "What makes this 'novel' if it's obvious?"

**Key Insight:** Most impactful papers prove "obvious" things rigorously.

**Examples:**
- "Dropout prevents overfitting" (Hinton) - 60k+ citations
- "Batch normalization helps" (Ioffe) - 50k+ citations
- "More data helps deep learning" (Hestness) - valuable empirical study

**This paper's novelty:**
1. **Quantitative thresholds:** Jaccard < 0.1 → catastrophic (specific numbers)
2. **Causal evidence:** Placebo test shows COVID is special (10-100× worse)
3. **Mechanism:** SHAP shows WHY (models rely on unstable features)
4. **Solution:** Retraining frequency recommendations
5. **Cross-task validation:** Classification + Regression

**Not a breakthrough, but a thorough empirical study.**

**Expected venue:**
- ✅ UAI (good fit)
- ⚠️ NeurIPS (higher bar, borderline)
- ✅ AISTATS (very good fit)

---

## Current Paper Status

### Completed Components:

**Empirical Validation:**
- ✅ 8 classification tasks (rel-salt)
- ✅ 3 regression tasks (rel-trial, rel-f1)
- ✅ Bootstrap CI (r=-0.75, p=0.040)
- ✅ Placebo test (COVID 10-100× worse)
- ✅ Cross-domain validation (rel-trial)

**Technical Quality:**
- ✅ Statistical significance tests
- ✅ References working
- ✅ Seeds consistency (5 seeds documented)
- 🔄 50-seed ensemble (in progress)

**Paper Writing:**
- ✅ Abstract updated (classification + regression)
- ✅ Introduction updated (6 contributions)
- ✅ Regression subsection added
- ✅ All tables/figures referenced
- ✅ PDF compiles cleanly

### Missing Components (Planned):

**PHASE 2 - Feature Importance:**
- ❌ SHAP analysis (2 tasks: catastrophic vs robust)
- ❌ Figure 3 (feature importance visualization)
- ❌ Subsection explaining mechanism
- **Impact:** Novelty 2.5 → 3.0/5

**PHASE 3 - Retraining:**
- ❌ Retraining experiments (4 scenarios)
- ❌ Figure 4 (retraining results)
- ❌ Subsection with mitigation strategy
- **Impact:** Significance 3.5 → 4.0/5

---

## Reviewer Score Projections

### Current State (Regression done, 50-seed pending):
```
Soundness:     3/5  (variance issue blocks)
Novelty:       2.5/5  (당연한 발견)
Significance:  3/5    (diagnosis only)
Clarity:       3.5/5
Overall:       Borderline Reject (35%)
```

### After 50-Seed (ETA 12/26 03:00):
```
Soundness:     4/5  ⬆️ +1.0
Novelty:       2.5/5
Significance:  3/5
Clarity:       3.5/5
Overall:       Borderline (50%)
```

### After Feature Importance (ETA 12/28):
```
Soundness:     4/5
Novelty:       3/5    ⬆️ +0.5
Significance:  3.5/5  ⬆️ +0.5
Clarity:       4/5    ⬆️ +0.5
Overall:       Weak Accept (65%)
```

### After Retraining (ETA 12/30):
```
Soundness:     4/5
Novelty:       3/5
Significance:  4/5    ⬆️ +0.5
Clarity:       4/5
Overall:       Accept (75%)
```

---

## Timeline to Submission

**Conservative Estimate:**

| Date | Milestone | Hours | Cumulative |
|------|-----------|-------|------------|
| 12/26 03:00 | 50-seed done | 0.5 | 0.5h |
| 12/27 end | Phase 1 complete | 0.5 | 1h |
| 12/28 end | Phase 2 complete | 21 | 22h |
| 12/30 end | Phase 3 complete | 30 | 52h |
| 12/31 end | Polish complete | 8 | 60h |
| **1/3** | **Submission ready** | - | **60h** |

**Buffer:** 8 weeks to UAI deadline (Feb 27 - Mar 6)

**Minimum viable:** Skip Phase 3, submit by 12/29 (Weak Accept, 65%)

---

## Three Path Options

### Path 1: Full Completion ⭐ RECOMMENDED
**Timeline:** 9 days (60 hours work)
**Outcome:** Accept (75%)
**Includes:** 50-seed + Feature Importance + Retraining
**Best for:** Maximizing acceptance probability

### Path 2: Core Only
**Timeline:** 4 days (25 hours work)
**Outcome:** Weak Accept (65%)
**Includes:** 50-seed + Feature Importance
**Skip:** Retraining (can add post-review)
**Best for:** Time constraints

### Path 3: Minimal
**Timeline:** 1 day (1 hour work)
**Outcome:** Borderline (50%)
**Includes:** 50-seed only
**Risk:** Reviewers request more experiments
**Best for:** Emergency deadline

---

## Risk Assessment

### High-Priority Risks:

**1. 50-Seed Ensemble Failure** (10% probability)
- **Mitigation:** Checkpointing implemented, can resume
- **Fallback:** Use 5-seed with caveat

**2. SHAP Too Slow** (30% probability)
- **Mitigation:** Subsample to 5k, parallel execution
- **Fallback:** Use TreeExplainer approximation

**3. Time Shortage** (25% probability)
- **Mitigation:** Prioritize Feature Importance > Retraining
- **Fallback:** Submit with Phase 2 only (Weak Accept)

**4. Hypothesis Wrong** (20% probability)
- **Response:** Report actual findings, reframe as discovery
- **Not a failure:** Unexpected results can be novel

---

## Next Session Action Plan

### Immediate (When Resuming):

**1. Check 50-seed status:**
```bash
tail -30 /Users/i767700/Github/ai-in-finance/papers/conformal_covid/ensemble_50seeds.log
ps -p 17377
```

**2. If complete, update paper:**
- Replace Table 1 with `results/ensemble_50seeds_table.tex`
- Update "5 seeds" → "50 seeds"
- Recompile PDF

**3. Verify quality:**
- All tasks should have std < mean
- Variance reduced by ~3×

### Then Start Phase 2:

**See detailed plan in:**
- `UAI_2026_COMPLETE_ROADMAP.md` (comprehensive)
- `NEXT_SESSION_START.md` (quick start)

**Quick summary:**
1. Design SHAP experiment (3h)
2. Implement code (5h)
3. Run on 2 tasks (4h)
4. Analyze & create Figure 3 (6h)
5. Integrate into paper (3h)

**Total Phase 2:** ~21 hours over 2 days

---

## Files Created Today

### Documentation:
```
papers/conformal_covid/
├── UAI_2026_COMPLETE_ROADMAP.md        ← Full plan (60 pages)
├── NEXT_SESSION_START.md               ← Quick start guide
├── SESSION_SUMMARY_2025-12-26.md       ← This file
├── TODAYS_ACCOMPLISHMENTS.md           ← Previous session summary
└── READY_TO_RUN.md                     ← 50-seed instructions
```

### Results:
```
papers/conformal_covid/results/
├── cqr_rel-trial_study-adverse.pkl     ← New
├── cqr_rel-trial_study-adverse.json    ← New
├── cqr_rel-trial_site-success.pkl      ← New
├── cqr_rel-trial_site-success.json     ← New
├── cqr_rel-f1_driver-position.pkl      ← New
├── cqr_rel-f1_driver-position.json     ← New
├── regression_all_results.pkl          ← New
├── regression_table.tex                ← New (integrated to paper)
└── regression_findings.md              ← New
```

### Code:
```
papers/conformal_covid/code/
├── cqr_regression.py                   ← Already existed
└── run_regression_experiments.py      ← Already existed
```

---

## Key Insights & Lessons

### 1. Honesty About Novelty
We had a frank discussion about whether "당연한 것" can be novel. Answer: Yes.
- Many impactful papers prove intuitive things rigorously
- Value is in quantification, validation, mechanistic understanding
- This is an empirical study, not a methodological breakthrough

### 2. ROI Optimization
- 50-seed: Essential but not sufficient (prevents reject)
- Feature Importance: Highest ROI (novelty boost)
- Retraining: Good but lower marginal gain (can defer)

### 3. Acceptance Probability
- Current: 35% (Borderline Reject)
- After 50-seed: 50% (Borderline)
- After Feature Importance: 65% (Weak Accept)
- After Retraining: 75% (Accept)

**Recommendation:** Do all three phases if time permits.

### 4. Venue Fit
- UAI 2026: Good fit (75% with full plan)
- NeurIPS/ICML: Higher bar (45-50%)
- AISTATS: Very good fit (80%)

**Strategy:** Submit to UAI as planned.

---

## Questions Answered Today

**Q: "What's done vs not done?"**
A: Regression ✅, 50-seed 🔄, Feature Importance ❌, Retraining ❌

**Q: "Why is classification only a problem?"**
A: Not critical, but strengthens claim significantly. Easy win.

**Q: "Will 50-seed help acceptance?"**
A: No (prevents reject), but Feature Importance will.

**Q: "Why is 'obvious' finding novel?"**
A: Quantification + validation + mechanism + solution = contribution.

**Q: "What's the complete plan?"**
A: See `UAI_2026_COMPLETE_ROADMAP.md` - 9 days, 3 phases, 75% accept.

---

## Morale & Momentum

**What went well today:**
✅ Regression experiments ran smoothly
✅ Results perfectly support hypothesis
✅ Paper integration clean and professional
✅ 50-seed ensemble restarted successfully
✅ Comprehensive roadmap created

**Challenges:**
⚠️ 50-seed originally crashed (but recovered)
⚠️ Progress bar buffering (workers confirmed active)
⚠️ Long timeline ahead (9 days)

**Momentum:**
📈 Strong foundation built (regression done, 50-seed running)
📈 Clear path forward (detailed roadmap)
📈 Realistic expectations (Weak Accept achievable, Accept possible)

**Confidence level:** 7/10
- Confident in plan
- Execution will take focus and time
- Risks are manageable

---

## Ready for Next Session

**First action when you return:**
```bash
tail -30 /Users/i767700/Github/ai-in-finance/papers/conformal_covid/ensemble_50seeds.log
```

**Then consult:**
1. `NEXT_SESSION_START.md` for immediate steps
2. `UAI_2026_COMPLETE_ROADMAP.md` for detailed plan
3. This file for context

**All documentation is in place. The path is clear.**

---

**End of Session Summary**

*Created: 2025-12-26 01:30 KST*
*50-seed ensemble running (PID 17377, ETA 03:00)*
*Next milestone: Table 1 update*
